Salix Pharma Balance Sheet - Annual (NASDAQ:SLXP)

Add to My Stocks
$172.81 $0 (0%) SLXP stock closing price Apr 01, 2015 (Closing)

A thorough fundamental analysis involves using data from Salix Pharma balance sheet, apart from other financial statements, to value the business. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Salix Pharma stock analysis. A company releases its balance sheet every year along with its annual results. The balance sheet shows total liabilities of $3.88B and shareholders equity of $238.24M. Salix Pharma revenue and Salix Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Salix Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2014201320122011201020092008
Marketable Securities-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets288.94M137.93M78.8M73.86M11.05M10.91M8.29M
Total Current Assets
Property Plant & Equipment64.87M48.65M42.92M41.24M21.34M17.05M13.88M
Accumulated Depreciation29.95M21.34M15.04M11.7M13.44M11.7M9.04M
Net Property Plant & Equipment
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges---2.58M---
Deposits & Other Assets94.26M37.55M35.91M21.87M8.53M16.81M17.99M
Total Assets
Notes Payable60M------
Accounts Payable45.64M32.63M31.11M21.14M18.47M15.64M10.09M
Current Portion Long-Term Debt921.05M------
Current Portion Capital Leases-------
Accrued Expenses179.2M97.66M81.06M80.39M45.75M59.98M27.44M
Income Taxes Payable-43.35M8.5M11.03M---
Other Current Liabilities269.37M246.83M140.19M97.87M60.53M32.04M34.03M
Total Current Liabilities
Deferred Taxes/Income284.51M42.37M64.25M78.63M---
Convertible Debt-882.05M857.2M340.28M323M47.29M60M
Long-Term Debt1.83B750M---15M15M
Non-Current Capital Leases9.13M8.61M7.55M6.23M1.44M2.23M2.89M
Other Long-Term Liabilities280.17M96.96M124.34M127.53M---
Total Liabilities
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus595.06M667.42M631.36M685.31M624.88M565.93M402.55M
Retained Earnings-355.48M71.65M-71.38M-135.62M-223.02M-195.96M-151.77M
Treasury Stock-------
Other Liabilities-1.4M1.72M--0.11M---
Shareholders Equity238.24M740.86M560.5M549.63M401.91M370.02M250.82M
Total Liabilities & Shareholders Equity4.12B2.94B1.87B1.31B851.54M543.04M401.14M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Salix Pharma historical stock prices and the current Salix Pharma stock price can tell you how the stock price has moved, whereas the Salix Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Salix Pharma owns and has monetary significance. SLXP assets grew from $2.94B in 2013 to $4.12B in 2014. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Salix Pharma is $3.88B. Shareholders' equity comes under liabilities as it is money the company owes the holders of SLXP stock.